

Oncology
Roger Belizaire, MD, PhD
Assistant Professor of Pathology at Harvard Medical School with appointments at the Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children’s Hos; Director in the Division of Transfusion Medicine at the Brigham and Women’s Hospital. His research focuses on oncogenic signaling and targeted therapies in my
Dr. Roger Belizaire is a physician at Dana-Farber Cancer Institute specializing in Transfusion Medicine, serving as Assistant Professor of Pathology at Harvard Medical School with appointments at the Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children’s Hos; Director in the Division of Transfusion Medicine at the Brigham and Women’s Hospital. His research focuses on oncogenic signaling and targeted therapies in my.
Is Dr. Belizaire right for you?
We'll build a personalized evaluation of Dr. Belizaire for your case, side-by-side against the top alternatives in their subspecialty.
- In-depth evaluation of Dr. Belizaire for your specific case
- Side-by-side comparison vs. the top alternatives
Fully credited toward membership if you join within 30 days
$25
Credentials
Board Certifications
- Clinical Pathology
Education & Training
- Washington University School of Medicine (MD)
- Brigham and Women's Hospital (Residency)
Years in Practice
14+ years
Peer Recognition
- Healthgrades — Healthgrades Honor Roll
Clinical Focus
Subspecialties
Conditions & Treatments
Insurance(s) Accepted
Please verify your coverage with the provider — plan participation can change.
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Dana-Farber/Brigham and Women's Cancer Center
Conditions Dr. Belizaire treats
Insurance accepted
Frequently asked
Does Dr. Belizaire accept Curative insurance?
Where does Dr. Belizaire practice?
What does Dr. Belizaire specialize in?
How long has Dr. Belizaire been practicing?
What is Dr. Belizaire's medical training?
Specialists similar to Dr. Belizaire
More medical oncology specialists in Massachusetts











